BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 16007073)

  • 1. Role of nucleophosmin in embryonic development and tumorigenesis.
    Grisendi S; Bernardi R; Rossi M; Cheng K; Khandker L; Manova K; Pandolfi PP
    Nature; 2005 Sep; 437(7055):147-53. PubMed ID: 16007073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleophosmin and cancer.
    Grisendi S; Mecucci C; Falini B; Pandolfi PP
    Nat Rev Cancer; 2006 Jul; 6(7):493-505. PubMed ID: 16794633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleophosmin is required for DNA integrity and p19Arf protein stability.
    Colombo E; Bonetti P; Lazzerini Denchi E; Martinelli P; Zamponi R; Marine JC; Helin K; Falini B; Pelicci PG
    Mol Cell Biol; 2005 Oct; 25(20):8874-86. PubMed ID: 16199867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression.
    Bouwman P; Drost R; Klijn C; Pieterse M; van der Gulden H; Song JY; Szuhai K; Jonkers J
    J Pathol; 2011 May; 224(1):10-21. PubMed ID: 21404276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of centrosomal association of nucleophosmin/B23 linked to Crm1 activity.
    Shinmura K; Tarapore P; Tokuyama Y; George KR; Fukasawa K
    FEBS Lett; 2005 Dec; 579(29):6621-34. PubMed ID: 16297385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse.
    Sportoletti P; Grisendi S; Majid SM; Cheng K; Clohessy JG; Viale A; Teruya-Feldstein J; Pandolfi PP
    Blood; 2008 Apr; 111(7):3859-62. PubMed ID: 18212245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants.
    Bolli N; Nicoletti I; De Marco MF; Bigerna B; Pucciarini A; Mannucci R; Martelli MP; Liso A; Mecucci C; Fabbiano F; Martelli MF; Henderson BR; Falini B
    Cancer Res; 2007 Jul; 67(13):6230-7. PubMed ID: 17616680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders.
    Caudill JS; Sternberg AJ; Li CY; Tefferi A; Lasho TL; Steensma DP
    Br J Haematol; 2006 Jun; 133(6):638-41. PubMed ID: 16704439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence.
    Cheng K; Grisendi S; Clohessy JG; Majid S; Bernardi R; Sportoletti P; Pandolfi PP
    Oncogene; 2007 Nov; 26(53):7391-400. PubMed ID: 17546053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of nucleophosmin in acute myeloid leukemia.
    Meani N; Alcalay M
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of NPM1 promoter hypermethylation in human myelodysplastic syndrome.
    Cheng YY; Chau D; Chan T; Gill H; Liang R; Kwong YL; Tse E
    J Clin Pathol; 2010 Nov; 63(11):1008-11. PubMed ID: 20924036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cloning and structural analysis of mouse genomic nucleophosmin gene].
    Xiang YG; Lu SY; Gu MM; Wang SY; Ren SX; Fu G; Wang ZG
    Yi Chuan Xue Bao; 2005 Jun; 32(6):641-9. PubMed ID: 16018192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of nucleophosmin (NPM) gene mutation in patients with acute myeloid leukemia and myelodysplastic syndromes].
    Zhang Y; Zhang MR; Yang L; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jul; 27(7):470-3. PubMed ID: 17147251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic instability in Gadd45a-deficient mice.
    Hollander MC; Sheikh MS; Bulavin DV; Lundgren K; Augeri-Henmueller L; Shehee R; Molinaro TA; Kim KE; Tolosa E; Ashwell JD; Rosenberg MP; Zhan Q; Fernández-Salguero PM; Morgan WF; Deng CX; Fornace AJ
    Nat Genet; 1999 Oct; 23(2):176-84. PubMed ID: 10508513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NPM1 mutations in myelodysplastic syndromes and acute myeloid leukemia with normal karyotype.
    Zhang Y; Zhang M; Yang L; Xiao Z
    Leuk Res; 2007 Jan; 31(1):109-11. PubMed ID: 16678898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases.
    Colombo E; Alcalay M; Pelicci PG
    Oncogene; 2011 Jun; 30(23):2595-609. PubMed ID: 21278791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythroid differentiation-associated gene interacts with NPM1 (nucleophosmin/B23) and increases its protein stability, resisting cell apoptosis.
    Zhang MJ; Ding YL; Xu CW; Yang Y; Lian WX; Zhan YQ; Li W; Xu WX; Yu M; Ge CH; Ning HM; Li CY; Yang XM
    FEBS J; 2012 Aug; 279(16):2848-62. PubMed ID: 22712502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.
    Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S
    Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of multifunctional nucleolar protein nucleophosmin (NPM1) by aurora kinase B is critical for mitotic progression.
    Shandilya J; Senapati P; Dhanasekaran K; Bangalore SS; Kumar M; Kishore AH; Bhat A; Kodaganur GS; Kundu TK
    FEBS Lett; 2014 Jun; 588(14):2198-205. PubMed ID: 24857377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleophosmin gene mutations promote NIH3T3 cell migration and invasion through CXCR4 and MMPs.
    Shao HY; Miao ZY; Hui-Chen ; Qin FX; Chen XC; Tan S; Zhang HJ; Wang L; Gao YJ; Yang ZL; Zhang L
    Exp Mol Pathol; 2011 Feb; 90(1):38-44. PubMed ID: 21122805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.